The two main approaches for discovering disease genes reveal distinct aspects of biology, a new study shows. While both ...
A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...
NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...
Iranian filmmaker Jafar Panahi’s latest feature, It Was Just an Accident, is among the leading nominees for this year’s Asia Pacific Screen Awards (APSA) with two nods, including the gong for Best ...
In the five years since Italy-based Chiesi Group established its rare disease division in Boston, the unit has landed regulatory approvals worldwide for 10 therapies — all small molecules and ...
Jeanette Henriquez, on the left, stands with her two children, Jasmine Henriquez and Dominic Henriquez. Dominic Henriquez was diagnosed with Hunter Syndrome in 2011 before the condition was added to ...
Not every actor is willing or able to take on what is arguably the most difficult role to play convincingly: themselves. Sometimes, these kinds of performances come off as trite or desperate. At their ...
OMAHA, Neb. (WOWT) - A free research study at Nebraska Medicine is offering you the chance to learn how your genetics could impact your health. An Omaha woman’s shocking results are taking her on a ...
CRISPR can edit DNA like text on a page — a tool powerful enough to cure disease or unleash chaos. Paired with AI, it could save millions… or become the deadliest weapon ever created Mike Johnson ...
In a much-anticipated move, Rockies general manager Bill Schmidt resigned on Wednesday. Now, the looming question is who will replace Schmidt? The Rockies said Wednesday that they will buck tradition ...
ZUG, Switzerland and BOSTON, Oct. 01, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...
Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct gene-editing experiments. The device, CRISPR-GPT, is an artificial intelligence lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results